Suppression of F1+2 (thrombin) generation in patients with DVT requires increased doses of heparin.
Korte
W
W
Schmid
L
L
D006493:Heparin / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D010314:Partial Thromboplastin Time; D010446:Peptide Fragments / Q000378:metabolism*; D011516:Prothrombin / Q000378:metabolism*; D013924:Thrombophlebitis / Q000097:blood* / Q000188:drug therapy*
D010446:Peptide Fragments; C045879:prothrombin fragment 1.2; D011516:Prothrombin; D006493:Heparin